Intelligent Bio Solutions (INBS) Short term Debt (2020 - 2022)

Intelligent Bio Solutions has reported Short term Debt for 3 years, with the latest figure at $1.0 million in Q3 2022.

• For the quarter ending Q3 2022, Short term Debt rose 1380.81% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2022 stood at $1.0 million (up 1380.81% YoY), and the FY2022 full-year result was $2.8 million, up 21190.87% from the prior year.
• Short term Debt for Q3 2022 stood at $1.0 million, down from $2.8 million in the prior quarter.
• The five-year high for Short term Debt was $2.8 million in Q2 2022, with the low at $9536.0 in Q4 2021.
• Average Short term Debt over 3 years is $773164.5, with a median of $250214.5 recorded in 2020.
• Year-over-year, Short term Debt slumped 99.25% in 2021 and jumped 21190.87% in 2022.
• Tracing INBS's Short term Debt over 3 years: stood at $431621.0 in 2020, then plunged by 97.79% to $9536.0 in 2021, then soared by 10584.96% to $1.0 million in 2022.
• The last three Short term Debt figures came in at $1.0 million (Q3 2022), $2.8 million (Q2 2022), and $9536.0 (Q4 2021), per Business Quant data.

Peer Comparison